Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptamer GroupFRA:P0J Days Inventory is 37.06 as of Dec. 2025, which is 41% below its 10-year median of 63.13. The stock has 4 warning signs investors should review. Among 637 Biotechnology companies, Aptamer Group ranks better than 87.76% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Aptamer Group's Average Total Inventories for the
six
months ended in Dec. 2025 was €0.09 Mil. Aptamer Group's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €0.42 Mil.
Hence, Aptamer Group's Days Inventory for the
six
months ended in Dec. 2025 was 37.06.
The historical rank and industry rank for Aptamer Group's Days Inventory or its related term are showing as below:
FRA:P0J'
s Days Inventory Range Over the Past 10 Years
Min: 43.77 Med: 63.13 Max: 96.64
Current: 43.77
During the past 6 years, Aptamer Group's highest Days Inventory was 96.64. The lowest was 43.77. And the median was 63.13.
FRA:P0J's Days Inventory is ranked better than 87.76% of 637
companies
in the Biotechnology industry
Industry Median: 183.16
vs FRA:P0J: 43.77
Aptamer Group's Days Inventory
declined
from Dec. 2024 (71.41) to Dec. 2025 (37.06).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Aptamer Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 4.92.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aptamer Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.09.
Aptamer Group (FRA:P0J) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aptamer Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aptamer Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Aptamer Group Days Inventory Related Terms
Aptamer Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Aptamer Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:P0J vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Aptamer Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptamer Group Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aptamer Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aptamer Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptamer Group (FRA:P0J) has a Days Inventory of 37.06 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aptamer Group and its competitors. This is 41% below median its historical median of 63.13. Over the past decade, Aptamer Group's Days Inventory has ranged from 43.77 to 96.64. According to the industry distribution chart, Aptamer Group ranks #78 out of 637 companies in the Biotechnology industry, placing it in the top 12.2%.
Is Aptamer Group's Days Inventory too high?
Aptamer Group's current Days Inventory of 37.06 is 41% below median its 10-year median of 63.13. Over the past 10 years, this metric has ranged from a low of 43.77 to a high of 96.64. The Biotechnology industry median Days Inventory is 183.16. Aptamer Group's value of 37.06 is 79.8% below this industry median. Based on the distribution chart, Aptamer Group ranks #78 out of 637 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Aptamer Group's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aptamer Group ranks #78 out of 637 companies for Days Inventory. This places Aptamer Group in the top 12% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.16. Aptamer Group's value of 37.06 is 79.8% below this benchmark. Historically, Aptamer Group's own Days Inventory has ranged from 43.77 to 96.64 over the past decade. While the company's 10-year median is 63.13 vs. the industry median of 183.16, Aptamer Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.16, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aptamer Group's current Days Inventory of 37.06 is 79.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aptamer Group and its competitors. For the Biotechnology industry, the median Days Inventory is 183.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptamer Group's current Days Inventory is 37.06, which is 41% below median its own 10-year median of 63.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptamer Group stock overvalued right now?
Aptamer Group (FRA:P0J) has a current Days Inventory of 37.06. The current Days Inventory is 37.06, which is 41% below median its 10-year median of 63.13 and 79.8% below the Biotechnology industry median of 183.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Aptamer Group (FRA:P0J), the current Days Inventory is 37.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses, Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:P0J has been successfully added to your 
